Showing results (1-10 of 507) with videos related to
Sort By:
Pageof 51
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2016
WT1 Mutation in Childhood CancerJocelyn Charlton, Kathy Pritchard-JonesPaediatric Drugs|January 4, 2019
Pharmacotherapeutic Management of Wilms Tumor: An UpdateRadna Minou Oostveen, Kathy Pritchard-JonesJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group StudySuzanne E Little, Sandra P Hanks, Linda King-Underwood, et al.Translational Pediatrics|February 3, 2016
Wilms' tumor: biology, diagnosis and treatmentElwira Szychot, John Apps, Kathy Pritchard-JonesFuture Oncology (London, England)|August 4, 2015
Biomarkers to detect Wilms tumors in pediatric patients: where are we now?Jocelyn Charlton, Vesna Pavasovic, Kathy Pritchard-JonesGenes & Development|March 5, 2015
The yin and yang of kidney development and Wilms' tumorsPeter Hohenstein, Kathy Pritchard-Jones, Jocelyn CharltonJournal of Clinical Pathology|October 30, 2007
c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumoursChris Jones, Maria Rodriguez-Pinilla, Maryou Lambros, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Expression of hepatocyte growth factor and its receptor met in Wilms' tumors and nephrogenic rests reflects their roles in kidney developmentRaisa Vuononvirta, Neil J Sebire, Boo Messahel, et al.Seminars in Pediatric Surgery|December 14, 2016
Wilms tumor: "State-of-the-art" update, 2016Sabine Irtan, Peter F Ehrlich, Kathy Pritchard-JonesFetal and Pediatric Pathology|December 10, 2016
Role of CD56 in Normal Kidney Development and Wilms TumorigenesisLi-Wei Yap, Jesper Brok, Kathy Pritchard-JonesPageof 51